A hallmark of tumor cells is an inability to control their proliferation, which implies that these cells are capable of bypassing cell cycle checkpoints and regulation by tumor suppressor signaling ...
Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A restrospective cohort study. PPHM 1501- An open-label, randomized, phase II trial of durvalumab (MEDI4736) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results